SYNTHETIC RECORD, NOT A REAL MEDICAL RECORD — Progress Note 3 — Focused Visit (Follow-up) — Cleopatra

PatientCleopatra
Date of birth1997-01-15
IdentifiersMRN HR-AC003-SYN; SSN (made up) 000-03-7095
Document date2026-05-12
AuthorNefeli Arvanitis-Osei, MD
CustodianSt. Posthumous Health Center

Readable copy of the C-CDA narrative, generated with the XML. Coded entries are in the XML file beside this page.

Chief Complaint

Prenatal visit at 19 weeks with the anatomy scans. [S]

History of Present Illness

Cleopatra returns at 19 weeks 0 days. The nausea stopped about two weeks ago and she has not needed doxylamine with pyridoxine since. She takes aspirin at bedtime without bruising or bleeding, the prenatal vitamin, and ferrous sulfate every other day. She has more energy and has begun to feel movements. She has no bleeding, pain, tightenings, headache, or urinary symptoms. The cell-free DNA result was low risk for trisomies 21, 18, and 13. She had the detailed anatomy scans this morning. [S]

ElementDetail
NauseaResolved
ScreeningCell-free DNA low risk
Fetal movementFirst movements felt
MedicinesAspirin, prenatal vitamin, ferrous sulfate every other day

Review of Systems

SystemResultFinding
ConstitutionalNegativeEnergy better
GastrointestinalNegativeNo nausea, vomiting, or constipation
GenitourinaryNegativeNo bleeding, leaking fluid, or urinary symptoms
ObstetricNegativeNo tightenings or pelvic pressure

4 systems reviewed. [S]

Medications

MedicationFrequencyRouteDatesStatusEvidence
Prenatal vitamin containing folic acid 0.4 mg, one tablet by mouth dailyOne tablet by mouth dailyOral route2026-03-03activeS
Ferrous sulfate 325 mg (65 mg elemental iron) oral tablet, one tablet by mouth every other dayOne tablet every other morning with water or orange juice, apart from tea, coffee, and calciumOral route2026-03-03activeS
Doxylamine succinate 10 mg / pyridoxine hydrochloride 10 mg delayed-release tablet, two tablets by mouth at bedtimeTwo tablets at bedtime; may add one in the morning if neededOral route2026-03-03 to 2026-05-12completedS
Aspirin 81 mg delayed-release tablet, one tablet by mouth at bedtimeOne tablet by mouth at bedtime from 12 weeks until deliveryOral route2026-03-24activeS

Allergies and Intolerances

AllergyReactionStatusEvidence
No known allergyactiveS

Vital Signs

DateMeasureValueUnitProvenance
2026-05-12Body height165cmS
2026-05-12Body weight61.5kgS
2026-05-12Body mass index (BMI) [Ratio]22.6kg/m2S
2026-05-12Systolic blood pressure104mm[Hg]S
2026-05-12Diastolic blood pressure62mm[Hg]S
2026-05-12Heart rate88/minS
2026-05-12Respiratory rate14/minS
2026-05-12Body temperature36.7CelS
2026-05-12Oxygen saturation in Arterial blood by Pulse oximetry99%S

Results

DateMeasureValueUnitReference rangeFlagProvenance
2026-05-12Hemoglobin [Mass/volume] in Blood11.1g/dL10.5-15 g/dLNormalS
2026-05-12Ferritin [Mass/volume] in Serum or Plasma24ng/mL30-150 ng/mLLowS
2026-05-12Cervix [Length] US41mm>=25 mmNormalS

Physical Exam

Vital signs recorded on 2026-05-12; see the Vital Signs section. [S]

SystemFinding
GeneralWell
AbdomenFundal height 22 cm, consistent with twins at 19 weeks; non-tender
FetalScans: normal anatomy in both twins; fetal hearts 150 and 146 per minute
Placenta and cervixFused anterior placenta clear of the cervix; transvaginal cervical length 41 mm
Urine dipstickProtein negative

Problems

ProblemClinical statusVerificationCodeProvenance
Uterus larger than dates in early pregnancy: 9 weeks by a certain last menstrual period, with the uterus about 12 to 13 weeks in size; nausea and vomiting heavier than in her first pregnancy; no bleeding; cause not yet known (multiple pregnancy, dating error, fibroids, or molar pregnancy)resolvedconfirmed O26.841S — Synthetic presenting finding anchored to the documented conception in the winter of 41 to 40 BC; it resolves when the ultrasound explains it.
Nausea and vomiting of pregnancy, moderate (PUQE score 9); keeping fluids down; no weight loss or ketonuriaresolvedconfirmed O21.9S — Synthetic; nausea is common and often heavier in early pregnancy with a large uterus.
Iron deficiency anemia in pregnancy: hemoglobin 10.8 g/dL, MCV 79 fL, ferritin 14 ng/mLactiveconfirmed O99.011S — Synthetic finding; it echoes no documented diagnosis.
Twin pregnancy, dichorionic diamniotic, second pregnancy (gravida 2, para 1): two live fetuses with a thick dividing membrane and a twin-peak (lambda) sign at 11 weeks; dated by her last period, confirmed by the crown-rump lengthsactiveconfirmed O30.041S — Synthetic modern diagnosis anchored to the documented twins of 40 BC; chorionicity is a modern finding and makes no claim about her real pregnancy.

Assessment and Plan

Protocol monitoring: items the monitoring protocol calls for at this visit. [S]

DomainMeasureIntervalStatusDetail
ExaminationBlood pressure and urine proteinEvery prenatal visitCompleted today104/62 mmHg; urine protein negative
ExaminationFetal hearts and fundal heightEvery prenatal visitCompleted todayFetal hearts 150 and 146 per minute; fundal height 22 cm
ExaminationWeight gain (about 17 to 25 kg for twins from a normal BMI)Every prenatal visitCompleted today61.5 kg, up 3.5 kg since intake
ImagingDetailed anatomy scans with placental locationAt 18 to 22 weeksCompleted todayNormal anatomy in both twins; placenta anterior and clear of the cervix
ImagingCervical lengthAt the anatomy scan; routine serial screening is not supported in twinsCompleted today41 mm by transvaginal scan
LaboratoryCell-free DNA screeningFrom 10 weeks, as she choseCompleted todayLow risk for trisomies 21, 18, and 13
LaboratoryHemoglobin and ferritinAt intake, at the anatomy-scan visit, at 24 to 28 weeks, and in the third trimesterCompleted todayHemoglobin 11.1 g/dL and ferritin 24 ng/mL; responding to oral iron
Medication safetyLow-dose aspirinDaily from 12 weeks until delivery; review at every visitCompleted todayTaken nightly since 12 weeks; no bruising or bleeding
ImagingGrowth scan with discordanceEvery four weeks from about 20 to 24 weeks in a dichorionic twin pregnancyDueFirst growth scan booked at 25 weeks
LaboratoryGestational diabetes screenAt 24 to 28 weeksDueAt 25 weeks
SurveyPerinatal mood screen (EPDS)Each trimesterDueSecond-trimester screen at 25 weeks
Self-managementPreterm labor warning signsEvery prenatal visitCompleted todayWarning signs reviewed

Goal progress:

Guideline basis: Multifetal Gestations: Twin, Triplet, and Higher-Order Multifetal Pregnancies: ACOG Practice Bulletin, Number 231 (2021); Prediction and Prevention of Spontaneous Preterm Birth: ACOG Practice Bulletin, Number 234 (2021); Screening for Fetal Chromosomal Abnormalities: ACOG Practice Bulletin, Number 226 (2020); Anemia in Pregnancy: ACOG Practice Bulletin, Number 233 (2021); Aspirin Use to Prevent Preeclampsia and Related Morbidity and Mortality: Preventive Medication (2021)

Follow-up: Prenatal visit with the growth scan, blood count, and glucose challenge at 25 weeks. Next scheduled visit 2026-06-23: prenatal visit at 25 weeks: growth scan, glucose challenge, and blood count. [S]